EURO RSCG Worldwide Awarded Aventis' Global Account

NEW YORK Euro RSCG Worldwide has won the estimated $100 million global review for Aventis Pharmaceuticals’ Lantus diabetes drug account, sources said.

The Havas agency competed against an initial round of five agencies: Interpublic Group’s McCann-Erickson, Omnicom Group’s TBWA Worldwide, Havas’ Euro RSCG, Grey Global Group’s Healthy Grey and WPP Group’s Young & Rubicam, said sources.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in